APENUnknown
Apollo Endosurgery, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Apollo Endosurgery, Inc. (APEN), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are APEN insiders buying or selling?
Apollo Endosurgery, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since January 2018, Trabud has recorded 27 Form 4 filings for APEN: 21 buys ($20.4M) and 6 sells ($3.5M).
Source: SEC EDGAR Form 4
Key Statistics (January 2018 – Oct 19, 2021)
Total Form 4 filings
27
SEC EDGAR
Insider filers
11
Insider buys (21)
$20.4M
Insider sells (6)
$3.5M
Insider sentiment
Net buyingNet insider flow of $16.8M in net buying since January 2018.
Recent APEN insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 19, 2021 | CPMG Inc | 10% Owner | Purchase | 683.9K | $7.75 | $5.3M | SEC ↗ |
| Oct 19, 2021 | Kent R Mcgaughy Jr | Director, 10% Owner | Purchase | 683.9K | $7.75 | $5.3M | SEC ↗ |
| Aug 21, 2021 | Chas Mckhann | President and CEO | Sale | 63.5K | $7.95 | $504.2K | SEC ↗ |
| Aug 20, 2021 | Chas Mckhann | President and CEO | Sale | 63.5K | $7.95 | $504.2K | SEC ↗ |
| Aug 12, 2021 | Jeffrey G. Black | Chief Financial Officer | Purchase | 25.0K | $8.75 | $218.8K | SEC ↗ |
| May 20, 2021 | David Pacitti | Director | Sale | 18.7K | $6.87 | $128.8K | SEC ↗ |
| May 20, 2021 | David Pacitti | Director | Sale | 18.7K | $6.87 | $128.8K | SEC ↗ |
| Apr 13, 2021 | Neil Gagnon | 10% Owner | Purchase | 303 | $5.48 | $1.7K | SEC ↗ |
| Mar 12, 2021 | John R Barr | Director | Purchase | 10.0K | $5.89 | $58.9K | SEC ↗ |
| Feb 24, 2021 | Neil Gagnon | 10% Owner | Purchase | 22.3K | $4.70 | $104.9K | SEC ↗ |
| Feb 22, 2021 | Neil Gagnon | 10% Owner | Purchase | 2.0K | $4.75 | $9.6K | SEC ↗ |
| Feb 8, 2021 | Neil Gagnon | 10% Owner | Purchase | 53.5K | $4.85 | $259.8K | SEC ↗ |
| Feb 5, 2021 | Neil Gagnon | 10% Owner | Purchase | 38.1K | $4.52 | $172.4K | SEC ↗ |
| Feb 3, 2021 | Neil Gagnon | 10% Owner | Purchase | 11.3K | $4.41 | $50.0K | SEC ↗ |
| Dec 17, 2020 | Neil Gagnon | 10% Owner | Purchase | 21.2K | $2.93 | $62.1K | SEC ↗ |
| Jul 21, 2020 | Kent R Mcgaughy Jr | Director, 10% Owner | Purchase | 1.8M | $1.25 | $2.2M | SEC ↗ |
| Jul 21, 2020 | CPMG Inc | 10% Owner | Purchase | 1.8M | $1.25 | $2.2M | SEC ↗ |
| May 14, 2019 | Todd Newton | Chief Executive Officer | Purchase | 25.0K | $3.53 | $88.3K | SEC ↗ |
| Jan 1, 2019 | STONEPINE CAPITAL, L.P. | 10% Owner | Sale | 250.0K | $3.00 | $750.0K | SEC ↗ |
| Dec 29, 2018 | STONEPINE CAPITAL, L.P. | 10% Owner | Sale | 500.0K | $3.00 | $1.5M | SEC ↗ |
| Nov 21, 2018 | STONEPINE CAPITAL, L.P. | 10% Owner | Purchase | 57.4K | $3.41 | $195.9K | SEC ↗ |
| Nov 6, 2018 | STONEPINE CAPITAL, L.P. | 10% Owner | Purchase | 300.0K | $5.00 | $1.5M | SEC ↗ |
| Jun 22, 2018 | Matthew S Crawford | Director, 10% Owner | Purchase | 363.5K | $5.50 | $2.0M | SEC ↗ |
| Jun 22, 2018 | Stefanie L. Cavanaugh | CFO, Treasurer, Secretary | Purchase | 4.5K | $5.50 | $25.0K | SEC ↗ |
| Jun 22, 2018 | Todd Newton | Chief Executive Officer | Purchase | 72.7K | $5.50 | $400.0K | SEC ↗ |
Showing the 25 most recent of 27 Form 4 filings for Apollo Endosurgery, Inc..
Most active APEN insiders
- Neil Gagnon7 filings
- STONEPINE CAPITAL, L.P.5 filings
- Chas Mckhann2 filings
- CPMG Inc2 filings
- David Pacitti2 filings
Ask anything about APEN insider activity
Use Trabud's AI agent to query Apollo Endosurgery, Inc.'s Form 4 history in plain English — "Show me APEN CEO purchases this year" or compare it against any other ticker.
Open the AI agentAPEN insider trading FAQ
Are Apollo Endosurgery, Inc. insiders buying or selling?
Apollo Endosurgery, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since January 2018, Trabud has recorded 27 Form 4 filings for APEN: 21 buys ($20.4M) and 6 sells ($3.5M). Over the full record that is net buying of $16.8M.
How many insiders trade APEN stock?
11 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Apollo Endosurgery, Inc.. The most recent filing was accepted on Oct 19, 2021.
Where does Trabud get APEN insider trading data?
All APEN insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.